Effect of low frequency ultrasound on combined rt-PA and eptifibatide thrombolysis in human clots

Thrombosis Research

Volumn 123, Issue 3, 2009, Pages 528-536

  Meunier, Jason M ^a   Holland, Christy K ^b,c   Pancioli, Arthur M ^a,c   Lindsell, Christopher J ^a   Shaw, George J ^a,b,c  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b 705 Engineering Research Center   (United States)

^c UNIVERSITY OF CINCINNATI   (United States)

Author keywords

Eptifibatide; Recombinant tissue Plasminogen activator; Thrombosis; Ultrasound

Indexed keywords

ALTEPLASE; EPTIFIBATIDE;

ARTICLE; BLOOD CLOT LYSIS; CONTROLLED STUDY; DRUG ACTIVITY; DRUG POTENTIATION; HUMAN; IN VITRO STUDY; PRIORITY JOURNAL; ULTRASOUND;

COMBINED MODALITY THERAPY; DRUG THERAPY, COMBINATION; FIBRINOLYTIC AGENTS; HUMANS; PEPTIDES; PLATELET AGGREGATION INHIBITORS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; RECOMBINANT PROTEINS; THROMBOLYTIC THERAPY; THROMBOSIS; TISSUE PLASMINOGEN ACTIVATOR; ULTRASONIC THERAPY;

EID: 57949114499     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2008.05.011     Document Type: Article

References (48)

1. Sura A.C., and Kelemen M.D. Early management of ST-segment elevation myocardial infarction. Cardiol Clin 24 1 (2006) 37-51
2. Tanne D., Bates V.E., Verro P., Kasner S.E., Binder J.R., Patel S.C., et al. Initial clinical experience with IV tissue plasminogen activator for acute ischemic stroke: a multicenter survey. The t-PA Stroke Survey Group. Neurology 53 2 (1999) 424-427
3. Protack C.D., Bakken A.M., Patel N., Saad W.E., Waldman D.L., and Davies M.G. Long-term outcomes of catheter directed thrombolysis for lower extremity deep venous thrombosis without prophylactic inferior vena cava filter placement. J Vasc Surg 45 5 (2007) 992-997 discussion 997
4. Sugimoto K., Hoffman L.V., Razavi M.K., Kee S.T., Sze D.Y., Dake M.D., et al. The safety, efficacy, and pharmacoeconomics of low-dose alteplase compared with urokinase for catheter-directed thrombolysis of arterial and venous occlusions. J Vasc Surg 37 3 (2003) 512-517
5. Alexandrov A.V., Molina C.A., Grotta J.C., Garami Z., Ford S.R., Alvarez-Sabin J., et al. Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke. N Engl J Med 351 21 (2004) 2170-2178
6. Basta G., Lupi C., Lazzerini G., Chiarelli P., L'Abbate A., and Rovai D. Therapeutic effect of diagnostic ultrasound on enzymatic thrombolysis. A in vitro study on blood of normal subjects and patients with coronary artery disease. Thromb Haemost 91 6 (2004) 1078-1083
7. Suchkova V.N., Baggs R.B., and Francis C.W. Effect of 40 kHz ultrasound on acute thrombotic ischemia in a rabbit femoral artery thrombosis model: Enhancement of thrombolysis and improvement in capillary muscle perfusion. Circulation 101 (2000) 2296-2301
8. Meunier J.M., Holland C.K., Lindsell C.J., and Shaw G.J. Duty cycle dependence of 120 kHz ultrasound enhanced thrombolysis in human clot. Ultrasound Med Biol 33 4 (2007) 576-783
9. Atar S., Luo H., Birnbaum Y., Nagai T., and Siegel R.J. Augmentation of in-vitro clot dissolution by low frequency high-intensity ultrasound combined with antiplatelet and antithrombotic drugs. J Thromb Thrombolysis 11 3 (2001) 223-228
10. Pancioli A.M., and Brott T.G. Therapeutic potential of platelet glycoprotein IIb/IIIa receptor antagonists in acute ischaemic stroke: scientific rationale and available evidence. CNS Drugs 18 14 (2004) 981-988
11. Sakharov D.V., Hekkenberg R.T., and Rijken D.C. Acceleration of fibrinolysis by high-frequency ultrasound: The contribution of acoustic streaming and temperature rise. Thromb Haemost 100 (2000) 333-340
12. Akiyama M., Ishibashi T., Yamada T., and Furuhata H. Low frequency ultrasound penetrates the cranium and enhances thrombolysis in vitro. Neurosurgery 43 4 (1998) 828-833
13. Francis C., Blinc A., Lee S., and Cox C. Ultrasound accelerates transport of recombinant tissue plasminogen activator into clots. Ultrasound Med Biol 21 3 (1995) 419-424
14. Everbach C., and Francis C.D. Cavitational mechanisms in ultrasound accelerated thrombolysis at 1 MHz. Ultrasound Med Biol 26 7 (2000) 1153-1160
15. Datta S., Coussios C.C., McAdory L.E., Tan J., Porter T., Courten-Meyers G., et al. Correlation of cavitation with ultrasound enhancement of thrombolysis. Ultrasound Med Biol 32 8 (2006) 1257-1267
16. Prokop A.F., Soltani A., and Roy R.A. Cavitational mechanisms in ultrasound-accelerated fibrinolysis. Ultrasound Med Biol 33 6 (2007) 924-933
17. Marinoni M., Ginanneschi A., Forleo P., and Amaducci L. Technical limits in transcranial Doppler recording: Inadequate acoustic windows. Ultrasound Med Biol 23 (1997) 1275-1277
18. Poster T., Federlein J., Przuntek H., and Bütner T. Insufficient and absent acoustic temporal bone window: Potential and limitations of transcranial contrast-enhanced color-coded sonography and contrast-enhanced power-based sonography. Ultrasound Med Biol 23 6 (1997) 857-862
19. Siegel R.J., Atar S., Fishbein M.C., Brasch A.V., Peterson T.M., Nagai T., et al. Noninvasive transcutaneous low frequency ultrasound enhances thrombolysis in peripheral and coronary arteries. Echocardiography 18 3 (2001) 247-257
20. Pfaffenberger S., Devcic-Kuhar B., Kollman C., Kastl S.P., Kaun C., Spiedl W.S., et al. Can a commercial diagnostic ultrasound device accelerate thrombolysis? An in vitro skull model. Stroke 36 (2005) 124-128
21. Tricoci P., Newby L.K., Kandzari D.E., and Harrington R.A. Present and evolving role of eptifibatide in the treatment of acute coronary syndromes. Expert Rev Cardiovasc Ther 5 3 (2007) 401-412
22. Rebeiz A.G., Johanson P., Green C.L., Crater S.W., Roe M.T., Langer A., et al. Comparison of ST-segment resolution with combined fibrinolytic and glycoprotein IIb/IIIa inhibitor therapy versus fibrinolytic alone (data from four clinical trials). Am J Cardiol 95 5 (2005) 611-614
23. Jaffe G.J., Green G.D., and Abrams G.H. Stability of recombinant tissue plasminogen activator. Am J Ophthalmol 108 1 (1989) 90-91
24. Winter P.M., Shukla H.P., Caruthers S.D., Scott M.J., Fuhrhop R.W., Robertson J.D., et al. Molecular imaging of human thrombus with computed tomography. Acad Radiol 12 Suppl 1 (2005) S9-S13
25. Yu X., Song S.K., Chen J., Scott M.J., Fuhrhop R.J., Hall C.S., et al. High-resolution MRI characterization of human thrombus using a novel fibrin-targeted paramagnetic nanoparticle contrast agent. Magn Reson Med 44 (2000) 867-872
26. Francis C.W., and Totterman S. Magnetic resonance imaging of deep vein thrombi correlates with response to thrombolytic therapy. Thromb Haemost 73 3 (1995) 386-391
27. Loren M., Fade-Garcia L.J., Toorado M.C., and Navarro J.L. Thrombus age and tissue plasminogen activator mediated thrombolysis in rats. Thromb Res 56 (1989) 67-76
28. Shaw G.J., Dhamija A., Bavani N., and Lindsell C.J. Effect of mild hypothermia on the thrombolytic efficacy of 120 kHz ultrasound enhanced thrombolysis in an in-vitro human clot model. Thromb Res 117 (2006) 603-608
29. Kaufman R.M. Uncommon cold: could 4 degrees C storage improve platelet function?. Transfusion 45 9 (2005) 1407-1412
30. Marinkovic S.V., Miliasavljevic M.M., Kovacevic M.S., and Stevia Z.D. Perforating branches of the middle cerebral artery: Microanatomy and clinical significance of their intracerebral segments. Stroke 15 6 (1958) 1022-1029
31. Tao X., Yu X.J., Bhattarai B., Li T.H., Jin H., Wei G.W., et al. Microsurgical anatomy of the anterior communicating artery complex in adult Chinese heads. Surg Neurol 65 (2006) 151-161
32. Diamond S.L., and Anand S. Inner clot diffusion and permeating during fibrinolysis. Biophys J 65 (1993) 2622-2643
33. Collet J.P., Montalescot G., Lesty C., and Weisel J.W. A structural and dynamic investigation of the facilitating effect of glycoprotein IIb/IIIa inhibitors in dissolving platelet-rich clots. Circ Res 90 4 (2002) 428-434
34. Cheng J.Y., Shaw G.J., and Holland C.K. In vitro microscopic imaging of enhanced thrombolysis with 120 kHz ultrasound in a human clot model. Acoust Res Lett Online 6 1 (2005) 25-29
35. Hynynen K., McDannold N., Sheikov N.A., Jolesz F.A., and Vykhodtseva N. Local and reversible blood-brain barrier disruption by noninvasive focused ultrasound at frequencies suitable for trans-skull sonications. Neuroimaging 24 (2005) 12-20
36. Brott T.G., Haley Jr. E.C., Levy D.E., Barsan W., Broderick J., Sheppard G.L., Spilker J., Kongable G.L., Massey S., Reed R., et al. Urgent therapy for stroke. Part I. Pilot study of tissue plasminogen activator administered within 90 minutes. Stroke 23 5 (1992) 632-640
37. Tanswell P., Seifried E., Stang E., and Krause J. Pharmacokinetics and hepatic catabolism of tissue-type plasminogen activator. Arzneimittelforschung 41 12 (1991) 1310-1319
38. Seifried E., Tanswell P., Ellbruck D., Haerer W., and Schmidt A. Pharmacokinetics and haemostatic status during consecutive infusion of recombinant tissue-type plasminogen activator. Thromb Haemost 61 3 (1989) 497-501
39. Boden W.E., Eagle K., and Granger C.B. Reperfusion strategies in acute ST-segment elevation myocardial infarction: a comprehensive review of contemporary management options. J Am Coll Cardiol 50 10 (2007) 917-929
40. Tardiff B.E., Jennings L.K., Harrington R.A., Gretler D., Potthoff R.F., Vorchheimer D.A., et al. Pharmacodynamics and pharmacokinetics of eptifibatide in patients with acute coronary syndromes: prospective analysis from PURSUIT. Circulation 104 4 (2001) 399-405
41. Gilchrist I.C., O'Shea J.C., Kosoglou T., Jennings L.K., Lorenz T.J., Kitt M.M., et al. Pharmacodynamics and pharmacokinetics of higher-dose, double-bolus eptifibatide in percutaneous coronary intervention. Circulation 104 4 (2001) 406-411
42. Kinsler L.E., Frey A.R., Coppens A.B., and Sanders J.V. Fundamentals of Acoustics. 4th Edition (2000), John Wiley & Sons, Inc., New York
43. Wyshelesky A., Iakobishvili Z., Matz I., Golovchiner G., Vaturi M., Siegel R.J., et al. There is synergism between high-intensity, low-frequency ultrasound and streptokinase but not with eptifibatide, heparin, and aspirin. Differential effects on fresh and aged blood clots. An in vitro study. Thromb Res 103 4 (2001) 337-344
44. Hankey G.J., and Eikelboom J.W. Antiplatelet drugs. Med J Aust 178 11 (2003) 568-574
45. Devcic-Kuhar B., Pfaffenberger S., Gherardini L., Mayer C., Gro?schl M., Kaun C., et al. Ultrasound affects distribution of plasminogen and tissue-type plasminogen activator in whole blood clots in vitro. Thromb Haemost 92 5 (2004) 980-985
46. Onundarsen P.T., Francis C.W., and Marder V.J. Depletion of plasminogen in vitro or during thrombolytic therapy limits fibrinolytic potential. J Lab Clin Med 120 (1992) 120-128
47. Francis C.W., Blinc A., Lee S., and Cox C. Ultrasound accelerates transport of recombinant tissue plasminogen activator into clots. Ultrasound Med Biol 21 3 (1995) 419-424
48. Datta S., Coussios C.C., McAdory L.E., Tan J., Porter T., De Courten-Myers G., et al. Correlation of cavitation with ultrasound enhancement of thrombolysis. Ultrasound Med Biol 32 8 (2006) 1257-1267